• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore , June 2

EuroCOR, a wholly owned subsidiary of Opto Circuits (India) Ltd (OCIL), has received CE approval for marketing and sale of Amadeus Supercross, a coronary dilation catheter and E-Wire, a guide wire for interventional use. Both products are used in Coronary Angioplasty (Percutaneous Transluminal Coronary Angioplasty — PTCA). The two products are expected to add 3-5 million and 1 million, respectively, per year to Opto's topline.

Mr Vinod Ramnani, Chairman & Managing Director, OCI, said, "The CE certification adds a global dimension to both the products as we can now tap almost 50 per cent of the large $8 billion PTCA market (stents, balloons, guidewires, guide catheters and accessories)".

Coronary artery dissections and spasms are common issues during an Angioplasty and Amadeus Supercross provides just the controlled safety balloon compliance for less dissections and low trauma PTCA. EuroCOR's E-Wire is used to guide an interventional device for restoring normal blood flow to an obstructed vessel.

More Stories on : Standards & Benchmarks | Medical & Surgical Equipments

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Baring India sells its entire stake in Mphasis to EDS

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line